| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |